Abstract
We treated a patient with biopsy-proven, chemotherapy-resistant testicular cancer liver metastasis using Y-90 selective internal radiation treatment. We chose yttrium-90 rather than surgery and ablation due to tumor location and size as well as the patient’s clinical history. The result was marked tumor response by positron emission tomography and computed tomography as well as significant improvement of the patient’s quality of life accompanied by a substantial decrease of his tumor markers.
References
Becker C et al (2011) C-arm computed tomography compared with positron emission tomography/computed tomography for treatment planning before radioembolization. Cardiovasc Intervent Radiol 34(3):550–556
Paprottka PM et al (2011) Practical vascular anatomy in the preparation of radioembolization. Cardiovasc Intervent Radiol. doi:10.1007/s00270-011-0169-z
Monsky WL et al (2011) Treatment planning and volumetric response assessment for yttrium-90 radioembolization: Semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy. Cardiovasc Intervent Radiol 34(2):306–318
McCaffrey JA, Bajorin DF, Motzer RJ (1998) Risk assessment for metastatic testis cancer. Urol Clin North Am 25(3):389–395
Dodd PM, Motzer RJ, Bajorin DF (1998) Poor-risk germ cell tumors. Recent developments. Urol Clin North Am 25(3):485–493
Schmoll HJ, Beyer J (1998) Prognostic factors in metastatic germ cell tumors. Semin Oncol 25(2):174–185
Goulet RJ Jr et al (1990) Hepatic resection for disseminated germ cell carcinoma. Ann Surg 212(3):290–294
Eastham JA et al (1994) Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 43(1):74–80
Vogl TJ et al (1999) Therapeutic options in non-resectable liver metastases. Percutaneous radiological interventions. Chirurg 70(2):133–140
Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8(11):1777–1781
Murthy R et al (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results. J Vasc Interv Radiol 16(7):937–945
Livraghi T et al (2003) Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The “test-of-time approach.”. Cancer 97(12):3027–3035
Ito H et al (2008) Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247(6):994–1002
Sato KT et al (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres―safety, efficacy, and survival. Radiology 247(2):507–515
Haydar AA et al (2010) (90)Y radioembolization: Embolization of the gastroduodenal artery is not always appropriate. Cardiovasc Intervent Radiol 33(5):1069–1071
Conflict of interest
We have no personal or financial conflict of interest. All authors, with the exception of C. S., have not entered into any agreement that could interfere with our access to the data on the research or with our ability to analyze the data independently or to prepare manuscripts and to publish them. C. S. receives research grant support and is a paid consultant for Sirtex Medical, Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sideras, P.A., Sofocleous, C.T., Brody, L.A. et al. Superselective Internal Radiation With Yttrium-90 Microspheres in the Management of a Chemorefractory Testicular Liver Metastasis. Cardiovasc Intervent Radiol 35, 426–429 (2012). https://doi.org/10.1007/s00270-011-0226-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-011-0226-7